Related Experiment Video

Updated: Jun 2, 2026

Assaying the Kinase Activity of LRRK2 in vitro
06:09

Assaying the Kinase Activity of LRRK2 in vitro

Published on: January 18, 2012

Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

Zhenyu Yue1, M Lenard Lachenmayer

  • 1Department of Neurology and Neuroscience, Mount Sinai School of Medicine, New York, New York, USA. zhenyu.yue@mssm.edu

Movement Disorders : Official Journal of the Movement Disorder Society
|May 4, 2011
PubMed

Insights

Genetic mouse models of leucine-rich repeat kinase 2 (LRRK2) are crucial for understanding Parkinson's disease. These models aid in studying early disease stages and identifying potential drug targets for LRRK2-related Parkinson's disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Dominantly inherited mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of familial Parkinson's disease.
  • Understanding LRRK2 biology is essential for elucidating Parkinson's disease etiology and developing interventions.
  • Genetic mouse models offer a platform to study LRRK2 pathophysiology.

Purpose of the Study:

  • To review the progress and utility of genetic LRRK2 mouse models.
  • To discuss their role in understanding early-stage Parkinson's disease progression.
  • To highlight their potential in identifying and validating drug targets.

Main Methods:

  • Systematic review of reported genetic mouse models of LRRK2.
  • Analysis of emerging Parkinson's disease-related pathologies in these models.
  • Discussion of model utility for drug discovery and compound screening.

Main Results:

  • Several genetic LRRK2 mouse models have been developed using diverse genetic strategies.
  • These models exhibit some Parkinson's disease-related pathological similarities, though often lack overt neuropathology or clinical syndromes.
  • Characterization is beginning to illuminate LRRK2 biology and pathophysiology.

Conclusions:

  • Genetic LRRK2 mouse models are valuable tools for Parkinson's disease research.
  • They provide insights into presymptomatic disease progression and LRRK2 function.
  • These models are critical for identifying and validating drug targets, including kinase inhibitors.

More Related Videos

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...